XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 6,291,171 $ 2,689,561 $ 16,464,609 $ 14,996,868
General and administrative 1,143,804 1,698,050 3,524,500 4,963,188
Total operating expenses 7,434,975 4,387,611 19,989,109 19,960,056
Operating loss (7,434,975) (4,387,611) (19,989,109) (19,960,056)
Other income (expense):        
Interest income 152,317 135,430 531,324 205,576
Other financing costs (Note 7)   (524,068)   (1,870,128)
Change in fair value of warrants (Note 7) 20,000 (7,862,108) 438,000 2,898,892
Total other income (expense), net 172,317 (8,250,746) 969,324 1,234,340
Net loss $ (7,262,658) $ (12,638,357) $ (19,019,785) $ (18,725,716)
Net loss per share (Note 9)        
Basic (dollars per share) $ (0.37) $ (0.97) $ (1.01) $ (1.64)
Diluted (dollars per share) $ (0.37) $ (0.97) $ (1.01) $ (1.89)
Weighted-average number of common shares used in computing net loss per share        
Basic 19,685,071 12,975,808 18,876,078 11,394,729
Diluted 19,685,071 12,975,808 18,876,078 11,461,298